Key result
Conservative warfarin management serves as an alternative for co-occurring peripartum cardiomyopathy and left atrial myxoma.
Why the study?
Although cardiac myxomas and PPCM are both more common in women, their co-occurrence had not previously been reported.
Case Report (n=1)
No
This case report documents the first known co-occurrence of a left atrial myxoma and peripartum cardiomyopathy, highlighting the necessity of conservative management and prophylactic warfarin anticoagulation when definitive surgical resection is hindered by resource limitations.
Answers are grounded in this paper and cite their sources.
Conservative warfarin anticoagulation may be feasible when myxoma resection is unavailable in peripartum cardiomyopathy; leaves open optimal long-term strategies.
Cardiac myxomas are the most prevalent cardiac tumours and occur more commonly in women, while peripartum cardiomyopathy (PPCM) is an important cause of heart failure (HF) in women. We present the first reported case, to our knowledge, of co-occurrence of left atrial myxoma with PPCM in a primiparous Nigerian woman who presented in HF shortly after delivery. She was managed conservatively and received prophylactic anticoagulation with warfarin. However, limited facilities for open heart surgery as well as severe financial constraints have thus far precluded the definitive treatment of surgical resection of the tumour.
No takes yet. Share an insight, caveat, or question.
Sani et al. (2026) conducted a case report in Peripartum cardiomyopathy with left atrial myxoma (n=1). Conservative medical management and prophylactic anticoagulation with warfarin was evaluated on Definitive surgical resection of the left atrial myxoma. Conservative management with warfarin anticoagulation was used for a primiparous woman with co-occurring peripartum cardiomyopathy and left atrial myxoma because financial constraints precluded surgical resection.
Synapse has enriched 10 related papers. Consider them for comparative context: